These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


115 related items for PubMed ID: 7542077

  • 1. Enhanced production and gene expression of interleukin-5 in patients with bronchial asthma: possible management of atopic diseases by down-regulation of interleukin-5 gene transcription.
    Okudaira H, Mori A, Suko M, Etoh T, Nakagawa H, Ito K.
    Int Arch Allergy Immunol; 1995; 107(1-3):255-8. PubMed ID: 7542077
    [Abstract] [Full Text] [Related]

  • 2. IL-5 production by CD4+ T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin A.
    Mori A, Suko M, Nishizaki Y, Kaminuma O, Kobayashi S, Matsuzaki G, Yamamoto K, Ito K, Tsuruoka N, Okudaira H.
    Int Immunol; 1995 Mar; 7(3):449-57. PubMed ID: 7540862
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: relationship to the eosinophil-active cytokines interleukin (IL)-5, granulocyte macrophage-colony-stimulating factor, and IL-3.
    Humbert M, Ying S, Corrigan C, Menz G, Barkans J, Pfister R, Meng Q, Van Damme J, Opdenakker G, Durham SR, Kay AB.
    Am J Respir Cell Mol Biol; 1997 Jan; 16(1):1-8. PubMed ID: 8998072
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Enhanced production and gene expression of IL-5 in bronchial asthma. Possible management of atopic diseases with IL-5 specific gene transcription inhibitor.
    Mori A, Suko M, Kaminuma O, Nishizaki Y, Nagahori T, Mikami T, Ohmura T, Hosino A, Asakura Y, Okudaira H.
    Adv Exp Med Biol; 1996 Jan; 409():439-50. PubMed ID: 9095279
    [No Abstract] [Full Text] [Related]

  • 9. Allergen-induced cytokine production in atopic disease and its relationship to disease severity.
    Leonard C, Tormey V, Burke C, Poulter LW.
    Am J Respir Cell Mol Biol; 1997 Sep; 17(3):368-75. PubMed ID: 9308924
    [Abstract] [Full Text] [Related]

  • 10. Cellular and molecular mechanisms of IL-5 synthesis in atopic diseases: a study with allergen-specific human helper T cells.
    Mori A, Kaminuma O, Suko M, Mikami T, Nishizaki Y, Ohmura T, Hoshino A, Asakura Y, Miyazawa K, Ando T, Okumura Y, Yamamoto K, Okudaira H.
    J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S56-64. PubMed ID: 9440546
    [Abstract] [Full Text] [Related]

  • 11. Secretion of the eosinophil-active cytokines interleukin-5, granulocyte/macrophage colony-stimulating factor and interleukin-3 by bronchoalveolar lavage CD4+ and CD8+ T cell lines in atopic asthmatics, and atopic and non-atopic controls.
    Till S, Li B, Durham S, Humbert M, Assoufi B, Huston D, Dickason R, Jeannin P, Kay AB, Corrigan C.
    Eur J Immunol; 1995 Oct; 25(10):2727-31. PubMed ID: 7589063
    [Abstract] [Full Text] [Related]

  • 12. Alveolar macrophages from atopic asthmatics, but not atopic nonasthmatics, enhance interleukin-5 production by CD4+ T cells.
    Tang C, Rolland JM, Li X, Ward C, Bish R, Walters EH.
    Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1120-6. PubMed ID: 9563728
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Enhanced expression of GM-CSF in differentiating eosinophils of atopic and atopic asthmatic subjects.
    Gauvreau GM, O'Byrne PM, Moqbel R, Velazquez J, Watson RM, Howie KJ, Denburg JA.
    Am J Respir Cell Mol Biol; 1998 Jul; 19(1):55-62. PubMed ID: 9651180
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Peripheral blood CD4 but not CD8 t-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: effect of glucocorticoid therapy.
    Corrigan CJ, Hamid Q, North J, Barkans J, Moqbel R, Durham S, Gemou-Engesaeth V, Kay AB.
    Am J Respir Cell Mol Biol; 1995 May; 12(5):567-78. PubMed ID: 7742019
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A novel phosphodiesterase inhibitor, T-440: possible management of eosinophilic inflammation by down-regulation of interleukin-5 production.
    Kaminuma O, Mori A, Suko M, Nishizaki Y, Kikkawa H, Ikezawa K, Okudaira H.
    Int Arch Allergy Immunol; 1996 May; 111 Suppl 1():16-8. PubMed ID: 8906105
    [Abstract] [Full Text] [Related]

  • 20. Vomitoxin-mediated IL-2, IL-4, and IL-5 superinduction in murine CD4+ T cells stimulated with phorbol ester calcium ionophore: relation to kinetics of proliferation.
    Ouyang YL, Azcona-Olivera JI, Murtha J, Pestka JJ.
    Toxicol Appl Pharmacol; 1996 Jun; 138(2):324-34. PubMed ID: 8658534
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.